UK Makes First Payments to Compensate Injury or Death from Vaccines | The Most Revolutionary Act

https://stuartbramhall.wordpress.com/2022/06/24/uk-makes-first-payments-to-compensate-injury-or-death-from-vaccines/

Jacqui Wise

British Medical Journal

The first compensation payments in the UK have been made to families who have been bereaved, or to people who have been injured, as a result of a covid-19 vaccine.

Vikki Spit from Cumbria is believed to be the first person to receive compensation, after her 48 year old partner, Zion, became ill eight days after receiving the AstraZeneca vaccine. Zion, a former rock singer, died at the Royal Victoria Infirmary in Newcastle in May 2021.

A handful of other people have received payments in the past few days under the government’s vaccine damage payment scheme (VDPS), which pays out up to a maximum of £120 000 (€140 000; $150 000).

Sarah Moore, a partner at the Hausfeld law firm, which is representing people seeking compensation, told The BMJ it was an important moment. “While the VDPS payments are very modest in amount, and will do very little to alleviate the financial difficulties with which many families are now struggling as a consequence of injury or bereavement, the fact of payment for some will mark a moment of vindication in that it is the clearest statement yet, by the government, that in some rare instances the covid-19 vaccines have caused very significant injury or death.”

However, it was “far too little, too late,” she said. “With a 60% disability eligibility criteria, a historical acceptance rate of 1.7%, and a maximum cap of £120 000, the inadequacies of the scheme mean that some families will have no choice but to look at litigation in order to access substantive financial support.”

Moore added that she believed that most of the payments so far have been made as a result of an individual experiencing vaccine induced immune thrombotic thrombocytopenia (VITT) or cerebral venous sinus thrombosis (CVST) after vaccination. But she said she knew of one payment for someone who had developed Guillain-Barré syndrome after covid-19 vaccination.

The NHS Business Services Authority, the body that handles the VDPS, confirmed that as of 20 May 2022 it had received 1681 claims in relation to covid-19 vaccines. A spokesperson emphasised that the VDPS was not a compensation scheme but one for payments to help ease the financial burden for those people who are severely disabled as a result of vaccination against a specific disease. All claims are medically assessed by an independent, third party medical assessor.

“The covid-19 vaccines are new. Establishing a causal relationship between the vaccines and their potential adverse effects is not a straightforward matter and has taken time,” the spokesperson told The BMJ. “It was vital we didn’t make assessments before the scientific evidence reached a more settled position, to avoid claims resulting in inconsistent outcomes, or disadvantaging claimants.

“We have to follow due process when progressing claims to ensure they are assessed in a fair and consistent way. As part of this process we must ensure that decisions are made based on all the evidence available. This requires gaining access to people’s medical notes and their previous medical history, so that the assessor can, having looked at all the evidence, determine whether there is a causal link and level of disability in each individual claim.”

The spokesperson said that the average (non-covid related) claim takes around six months to process from the date a claimant’s medical records are requested, because of the need to gather records from the claimants’ GPs, medical care providers, local authorities, or other relevant healthcare providers. “This can vary from case to case, and for covid-19 claims it has taken longer. We understand the frustration this is causing for claimants, and we appreciate their continued patience. We have scaled up a dedicated team of caseworkers to help speed up this process, support claimants through the application process, and provide regular updates on the progress of claims.

“Based on current timescales, once medical records have been sent for assessment, we expect to receive an outcome for most cases from the independent medical assessor within 12 weeks.”

Via https://www.bmj.com/content/377/bmj.o1565.short

CDC Admits It Never Monitored VAERS for COVID Vaccine Safety Signals | Aletho News

https://alethonews.com/2022/06/22/cdc-admits-it-never-monitored-vaers-for-covid-vaccine-safety-signals/

By Josh Guetzkow, Ph.D. | The Defender | June 21, 2022

In a stunning development, the Centers for Disease Control and Prevention (CDC) last week admitted — despite assurances to the contrary — the agency never analyzed the Vaccine Adverse Event Reporting System (VAERS) for safety signals for COVID-19 vaccines.

The admission was revealed in response to a Freedom of Information Act (FOIA) request submitted by Children’s Health Defense (CHD).

In September 2021, I published an article in The Defender in which I used the CDC’s published methodology to analyze VAERS for safety signals from COVID-19 vaccines.

The signals were loud and clear, leading me to wonder “why is nobody listening?”

Instead, I should have asked, “Is anybody even looking for them?”

After that article was published, I urged CHD’s legal team to submit a FOIA request to the CDC about its VAERS monitoring activities.

Since CDC officials stated publicly that “COVID-19 vaccine safety monitoring is the most robust in U.S. history,” I had assumed that at the very least, CDC officials were monitoring VAERS using the methods they described in a briefing document posted on the CDC website in January 2021 (and updated in February 2022, with minor changes).

I was wrong.

The lynchpin of their safety monitoring was to mine VAERS data for safety signals by calculating what are known as proportional reporting ratios (PRR’s).

This is a method of comparing the proportion of different types of adverse events reported for a new vaccine to the proportion of those events reported for an older, established vaccine.

If the new vaccine shows a significantly higher reporting rate of a particular adverse event relative to the old one, it counts as a safety signal that should then trigger a more thorough investigation.

The briefing document states, “CDC will perform PRR data mining on a weekly basis or as needed.”

And yet, in the agency’s response to the FOIA request, it wrote that “no PRRs were conducted by CDC. Furthermore, data mining is outside of the agency’s purview.”

The agency suggested contacting the U.S. Food and Drug Administration (FDA), which was supposed to perform a different type of data mining, according to the briefing document.

CDC officials repeatedly claimed they have not seen safety signals in VAERS.

For example, on April 27, 2021, CDC Director Dr. Rochelle Walensky stated the CDC did not see any signals related to heart inflammation.

But a PRR calculation I did using the number of myo/pericarditis reports listed in the first table produced by the CDC obtained via the FOIA request reveals clear and unambiguous safety signals relative to the comparator vaccines mentioned in the briefing document (i.e., flu vaccines, FLUAD and Shingrix).

The table is dated April 2, 2021, almost four weeks before she made those remarks.

In fact, among the 15 adverse events for adults included in that week’s tabulations, PRRs I calculated also show loud-and-clear safety signals for acute myocardial infarction, anaphylaxis, appendicitis, Bell’s palsy, coagulopathy, multisystem inflammatory syndrome in adults (MIS-A), stroke and death.

The actual monitoring the CDC did diverges from the one promised in the briefing document in other ways.

For example, the CDC never created tables of the top 25 adverse events reported in the previous week, tables comparing different vaccine manufacturers, or tables of auto-immune diseases.

And it only began monitoring in early April 2021, even though reports from COVID-19 vaccines had been flooding VAERS since mid-December of the previous year.

To be clear, VAERS is not the only database the CDC uses to monitor COVID-19 vaccine safety.

For example, the CDC sponsored several studies of COVID-19 safety using the Vaccine Safety Datalink (VSD), which is comprised of millions of medical records from HMO’s across several states.

Those studies do not raise many safety concerns. However, they make many questionable methodological choices.

To give one example, a major safety study based on VSD data published in September 2021, in “JAMA,” compares adverse event rates that occur within 1-21 days of vaccination to the rate of occurrence from 22 to 42 days after vaccination.

It makes no comparison between vaccinated and unvaccinated individuals, or before vaccination versus after in the same individuals.

Moreover, the VSD is far from infallible, having failed initially to detect the increase in myocarditis rates.

In contrast, although calculating PRR’s is a blunt pharmacovigilance tool and far from perfect, it nevertheless has the advantage of being straightforward and difficult to manipulate with statistical sleight of hand.

PRRs are one of the oldest, most basic and most well-established tools of pharmacovigilance. The calculations are so straightforward that the CDC automated it several years ago, so it could have been done at the press of a button.

It simply beggars belief that the CDC failed to do this simple calculation. Even now, a paper published by CDC staff in March on the safety of the mRNA COVID-19 vaccines remains purely descriptive with no PRR calculation.

Meanwhile, a study published by a researcher not affiliated with the CDC in February in “Frontiers in Public Health” analyzes VAERS and EudraVigilance data using a method similar to PRRs, revealing clear and concerning safety signals.

And while it is true that VAERS is not the only database the CDC can use to monitor COVID-19 vaccine safety, it is of critical importance because it can reveal signals much faster than any other method — if anybody cares to look for them.

It remains to be seen if the FDA was properly monitoring VAERS. That will be the subject of a future FOIA request.

But even if it was, it doesn’t change the fact that the CDC completely failed in its promise to monitor VAERS for safety signals.

© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

Death spike in Australia, and everywhere else | The Wentworth Report

https://wentworthreport.com/2022/06/14/death-spike-in-australia-and-everywhere-else/

Death spike in Australia, and everywhere else. By Rebecca Weisser.

The taboo consideration that cannot be raised in polite company is the Covid mass vaccination program. It is an article of faith that the vaccine is ‘safe and effective’ and to raise a scintilla of doubt is anathema, punishable by excommunication. Nonetheless, since the program began on 22 February almost 130,000 adverse events have been reported to the Therapeutic Goods Administration (TGA) including 874 deaths. …

This mortality rate is not normal. Before the Covid vaccines, the TGA received only 3,000-4,000 adverse event reports for all vaccines per year and only 2-3 reports of death. Yet to the TGA, apparently, all these deaths, except for 11 following AstraZeneca vaccines, were just a coincidence, even the 12 deaths from myocarditis, a recognised side effect of the mRNA vaccines. …

Yet it is the extraordinary diversity of the adverse reactions reported in response to Covid vaccines that is striking, and the way in which they mirror the myriad morbidities associated with Covid.

An unwelcome possibility:

What could explain this? Research from Linkoping University, Sweden, published in the Journal of the American Chemical Society, offers a chilling explanation.

The spike protein, of which Covid vaccines induce the body to produce trillions, prompts the immune system to dispatch white blood cells which use an enzyme to cut it up. Unfortunately, the S1 section of the cleaved spike is highly amyloidogenic, meaning it rapidly induces the misfolding of proteins to form insoluble fibrils. Deposits of fibrils in organs and tissues throughout the body — heart, liver, kidneys, spleen, brain and blood — produce localised and systemic disorders including clotting, cardiac failure, seizures, neurodegeneration and death.

If the Swedish research is correct, we have probably not seen the last of the excess mortality. But don’t expect anyone to mention it, anytime soon.

For more on that research, see here and here.

hat-tip Stephen Neil, Stephen S.

Australian Doctors Finally Speak Out! – Conference Of Conscience – Part 1 | Aletho News

https://alethonews.com/2022/05/22/australian-doctors-finally-speak-out-conference-of-conscience-part-1/

For the first time in a conference of this nature, a group of brave Australian doctors have finally decided to speak out about what they and their patients have been subjected to, the ways the government and TGA have skewed the safety and efficacy data of the COVID-19 vaccines, purposeful suppression of early treatment that could have saved hundreds of thousands of lives, and the danger of continuing the COVID-19 vaccination program.

Australia and the whole world is currently at risk. The World Health Organization who is largely responsible for millions of deaths globally is currently proposing a global Pandemic Treaty which seeks to give the WHO complete control over every country. More information about this can be found on zeeemedia.com.

Stay tuned for Part 2.

How Has Monkeypox Spread All Over the Globe at Lightning Speed?

https://counterinformation.wordpress.com/2022/05/21/how-has-monkeypox-spread-all-over-the-globe-at-lightning-speed%ef%bf%bc/

For decades, a few scientists have voiced concerns that the monkeypox virus could have become better at infecting people—ironically because we eradicated its relative, smallpox, in the late 1970s. The smallpox vaccine incidentally protected against monkeypox. And when new generations were born into a world without either smallpox or smallpox-vaccination campaigns, they grew up vulnerable to monkeypox. In the Democratic Republic of Congo, this dwindling immunity meant that monkeypox infections increased 20-fold in the three decades after smallpox vanished, as Rimoin showed in 2010. That gives the virus more chances to evolve into a more transmissible pathogen in humans. To date, its R0—the average number of people who catch the disease from one infected person—has been less than 1, which means that outbreaks naturally peter out. But it could eventually evolve above that threshold, and cause more protracted epidemics, as Bergstrom simulated in 2003. “We saw monkeypox as a ticking time bomb,” he told me.

Meanwhile, authorities are claiming that it seems to be particularly spreading among men that have sex with other men. The following comes from CNN

WHO/Europe | Q&A on hepatitis in children

https://www.euro.who.int/en/health-topics/communicable-diseases/hepatitis/news/news/2022/4/q-and-a-on-hepatitis-in-children

What is acute hepatitis?

It is a term used to describe an acute inflammation of the liver. It can be due to a range of infectious and non-infectious causes. There are 3 main types of acute viral hepatitis – hepatitis A, B and C. Viral hepatitis D and E are more unusual, particularly in higher income settings.

What makes this outbreak unusual?

Severe acute hepatitis is unusual in young children. The initial report of a
possible increase in cases came from Scotland. This then led to alerts being raised elsewhere in the United Kingdom and globally, with people then looking for and finding more cases.

What we know is that the
common viruses that cause acute viral hepatitis have not been detected in these patients. Also, international travel or links to other countries, based on the currently available information, have not been
identified as important factors.

How worried should we be?

This should be taken seriously – though these are rare events….

Multi-Country – Acute, severe hepatitis of unknown origin in children

https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376

Outbreak at a glance:

Since the WHO Disease Outbreak News on Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland
was published on 15 April 2022, there have been continuing further
reports of cases of acute hepatitis of unknown origin among young
children. It is not yet clear if there has been an increase in hepatitis
cases, or an increase in awareness of hepatitis cases that occur at the
expected rate but go undetected. While adenovirus is a possible
hypothesis, investigations are ongoing for the causative agent.

Outbreak overview

As of 21 April 2022,..

Сase of rare disease confirmed in England — RT World News

https://www.rt.com/news/555127-monkeypox-uk-case-disgnosed/

7 May, 2022 15:53

Сase of rare disease confirmed in England

There’s no cure for the Africa-linked infection,
which can cause severe disease in some people, British medics say
Сase of rare disease confirmed in England
A rare case of monkeypox has been confirmed in England, the UK Health Security Agency (UKHSA) announced on Saturday.

The
agency emphasized that monkeypox is a rare viral infection that doesn’t
spread easily between people. For most, it is a mild disease that
disappears within a few weeks but some can develop severe illness.

The
patient who has been diagnosed with monkeypox had recently arrived in
the UK from Nigeria, and is being treated at the infectious disease
isolation unit of Guy’s and St. Thomas’ Hospital in Central London.

As
a precautionary measure, UKHSA experts are working closely with NHS
colleagues and will be contacting people who might have been in close
contact with the individual to provide information and health advice,” the UKHSA said.

The agency considers the overall risk to the general public “very low.”

Monkeypox
is similar to human smallpox, which was eradicated in 1980, and can be
confused with chickenpox. Its initial symptoms include fever, headache,
muscle aches, backache, swollen lymph nodes, chills and exhaustion. A
rash often begins on the face and then spreads to other parts of the
body.

According to the UK National Health Service (NHS), monkeypox
can be caught from infected wild animals in parts of West and Central
Africa.

It’s thought to be spread by rodents, such as rats, mice and squirrels,” the NHS says.

Only
a few people have been diagnosed with monkeypox in the UK and all of
them traveled to West Africa or were close contacts of someone who had
traveled there.

A 2003 monkeypox outbreak in the United States was traced to a pet store where small mammals from Ghana were sold.

Although
monkeypox is generally milder than smallpox, the death rate among
infected people in Africa can be as high as 10%, according to the US
Centers for Disease Control and Prevention (CDC).

There is
currently no cure for the virus, although the smallpox vaccine is
believed to prevent infection, according to the NHS and CDC.

Covid death tolls: Australia leads the world | The Wentworth Report

https://wentworthreport.com/2022/05/07/covid-death-tolls-australia-leads-the-world/

Covid death tolls: Australia leads the world. By Naomi Grimley.

The WHO believes many countries undercounted the numbers who died from Covid – only 5.4 million were reported. … The measure used by the WHO is called excess deaths — how many more people died than would normally be expected based on mortality in the same area before the pandemic hit.

These calculations also take into account…

…charts…